Center J R, Nguyen T V, Sambrook P N, Eisman J A
Bone and Mineral Research Division, Garvan Institute of Medical Research, Sydney, Australia.
J Bone Miner Res. 2000 Jul;15(7):1405-11. doi: 10.1359/jbmr.2000.15.7.1405.
Low testosterone has been associated with hip fracture in men in some studies. However, data on other hormonal parameters and fracture outcome in men is minimal. This study examined the association between free testosterone (free T) estradiol (E2), sex hormone-binding globulin (SHBG), 25-hydroxyvitamin D [25(OH)D], parathyroid hormone (PTH), insulin-like growth factor I (IGF-I), and fracture in 437 elderly community-dwelling men. Age, height, weight, quadriceps strength, femoral neck bone mineral density (FN BMD), and fracture data (1989-1997) also were obtained. Fractures were classified as major (hip, pelvis, proximal tibia, multiple rib, vertebral, and proximal humerus) or minor (remaining distal upper and lower limb fractures). Fifty-four subjects had a fracture (24 major and 30 minor). There was no association between minor fractures and any hormonal parameter. Risk of major fracture was increased 2-fold for each SD increase in age, decrease in weight and height, and increase in SHBG, and risk of major fracture was increased 3-fold for each SD decrease in quadriceps strength, FN BMD, and 25(OH)D (univariate logistic regression). Independent predictors of major fracture were FN BMD, 2.7 (1.5-4.7; odds ratio [OR]) and 95% confidence interval [CI]); 25(OH)D, 2.8 (1.5-5.3); and SHBG, 1.7 (1.2-2.4). An abnormal value for three factors resulted in a 30-fold increase in risk but only affected 2% of the population. It is not immediately apparent how 25(OH)D and SHBG, largely independently of BMD, may contribute to fracture risk. They may be markers for biological age or health status not measured by methods that are more traditional and as such may be useful in identifying those at high risk of fracture.
在一些研究中,低睾酮已被证实与男性髋部骨折有关。然而,关于男性其他激素参数与骨折结局的数据却非常有限。本研究调查了437名居住在社区的老年男性体内游离睾酮(游离T)、雌二醇(E2)、性激素结合球蛋白(SHBG)、25-羟基维生素D [25(OH)D]、甲状旁腺激素(PTH)、胰岛素样生长因子I(IGF-I)与骨折之间的关联。同时还获取了他们的年龄、身高、体重、股四头肌力量、股骨颈骨密度(FN BMD)以及骨折数据(1989 - 1997年)。骨折被分为严重骨折(髋部、骨盆、胫骨近端、多根肋骨、脊椎和肱骨近端)或轻微骨折(其余上肢和下肢远端骨折)。54名受试者发生了骨折(24例严重骨折和30例轻微骨折)。轻微骨折与任何激素参数之间均无关联。在单因素逻辑回归分析中,年龄每增加一个标准差、体重和身高每降低一个标准差以及SHBG每升高一个标准差,严重骨折的风险就会增加2倍;股四头肌力量、FN BMD和25(OH)D每降低一个标准差,严重骨折的风险则会增加3倍。严重骨折的独立预测因素为FN BMD,比值比(OR)为2.7(1.5 - 4.7),95%置信区间(CI);25(OH)D,OR为2.8(1.5 - 5.3);以及SHBG,OR为1.7(1.2 - 2.4)。三个因素值异常会使风险增加30倍,但仅影响2%的人群。目前尚不清楚25(OH)D和SHBG在很大程度上独立于骨密度是如何导致骨折风险增加的。它们可能是生物学年龄或健康状况的标志物,而传统方法并未对这些进行测量,因此在识别骨折高危人群方面可能具有一定作用。